Biomarkers such as arginase-1 (ARG1) and argininosuccinate synthase 1 (ASS1) are differentially expressed and contribute to immunosuppressive tumor microenvironments, offering insight into immune evasion mechanisms (Chen et al., 2021). The gene discussed is ASS1; the disease is neoplasm.